AP
AGIO icon

Atwood & Palmer’s Agios Pharmaceuticals AGIO Stock Holding History

Atwood & Palmer’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-110
Closed -$8K – 398
2015
Q3 		$8K Buy
+110
New +$10.8K ﹤0.01% 347

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atwood & Palmer's AGIO Position: Q4 2015 in Review

Atwood & Palmer sold out of Agios Pharmaceuticals (AGIO) in Q4 2015, closing a stake of 110 shares — an estimated $8K sold.

Atwood & Palmer first reported a position in AGIO in Q3 2015 and held it in 1 quarter. The position peaked at $8K in Q3 2015. 144 funds tracked by Wall St. Rank hold AGIO as of Q4 2015.

  • Atwood & Palmer reported no remaining Agios Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Atwood & Palmer sold 110 Agios Pharmaceuticals shares in Q4 2015, an estimated $8K.
  • Atwood & Palmer first reported a position in Agios Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Atwood & Palmer's Agios Pharmaceuticals position peaked at $8K in Q3 2015.
  • 144 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2015.

Based on Atwood & Palmer's 13F filing for Q4 2015, filed 28 Jan 2016.